Emotions, Dopamine, Brain and Body
- Conditions
- Emotions
- Interventions
- Drug: DomperidonDrug: Placebo
- Registration Number
- NCT06171087
- Lead Sponsor
- German Institute of Human Nutrition
- Brief Summary
The study will examine the influence of domperidon (20mg) on brain and hebavioral responses to emotional stimuli (videos) using fMRI
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Domperidon Domperidon Participants recieve 10mg of Domperidon, 45 minutes before the start of the experiment Placebo Placebo Participants recieve a placebo pill, 45 minutes before the start of the experiment
- Primary Outcome Measures
Name Time Method Brain responses to emotions 1-3 hour after drug administratrion fMRI brain responses to emotional videos comparing placebo vs domperidon condition. Specifically: dampened brain response to disgust and high arousing videos in domperidon condition
Body (stomach, heart, skin conductance) response to emotions 1-3 hour after drug administratrion Physiological responses to emotional videos comparing placebo vs domperidon condition. Specifically: Reduction in Tachyhastria for disgust and high arousing videos in domperidone condition
Behavioral responses to emotions 1-3 hour after drug administratrion Changes in subjective reports to emotional videos comparing placebo vs domperidon condition. Specifically: Reduction in disgust and arousal ratings to disgust and high arousing videos
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
German Institute of Human Nutrition
🇩🇪Potsdam, Brandenburg, Germany